Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells.

Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Abstract Text:

    hidekazu oshinaHidekazu Oshina,shinichi sotomeShinichi Sotome,toshitaka yoshiiToshitaka Yoshii,ichiro torigoeIchiro Torigoe,yumi sugataYumi Sugata,hidetsugu maeharaHidetsugu Maehara,eriko marukawaEriko Marukawa,ken omuraKen Omura,kenichi shinomiyaKenichi Shinomiya,

    Human bone marrow-derived mesenchymal cells (hBMMCs) originate from cell populations in the bone marrow and are capable of differentiating along multiple mesenchymal lineages. To differentiate hBMMCs into osteoblasts, adipocytes and chondrocytes, dexamethasone has been used as a differentiation reagent. We hypothesized that dexamethasone would augment the responsiveness of BMMCs to other differentiation reagents and not define the lineage. This study investigated the effect of continuous treatment with 100 nM dexamethasone on the differentiation of BMMCs into three different lineages. hBMMCs cultured with continuous dexamethasone treatment (100 nM) exhibited higher mRNA expression levels of osteogenic markers and higher positive rates of colony forming unit assays for osteogenesis compared to hBMMCs treated with dexamethasone only during the differentiation culture. Furthermore, continuous dexamethasone treatment augmented bone formation capability of monkey-derived BMMCs in a bone induction experimental model at an extra skeletal site. In addition, continuously dexamethasone-treated hBMMCs formed larger chondrogenic pellets and expressed SOX9 at higher level than the control BMMCs. Likewise, continuous dexamethasone treatment facilitated adipogenic differentiation based on mRNA level and colony forming unit analysis. To investigate the mechanism of the augmentation of differentiation, further studies on apoptosis were conducted. The studies indicated that dexamethasone selectively induced apoptosis of some populations of hBMMCs which were thought to have poor differentiation capability.

    Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Publishing Authors By Initials

    h oshinaH Oshina,s sotomeS Sotome,t yoshiiT Yoshii,i torigoeI Torigoe,y sugataY Sugata,h maeharaH Maehara,e marukawaE Marukawa,k omuraK Omura,k shinomiyaK Shinomiya,

    For similar physiological processes: growth and development: morphogenesis: embryonic and fetal development: organogenesis: musculoskeletal development: bone development: osteogenesis research abstracts see: physiological processes: growth and development: morphogenesis: embryonic and fetal development: organogenesis: musculoskeletal development: bone development: osteogenesis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Bone

    VOLUME: 41

    Page Numbers: 575-83

    Journal Abbreviation: Bone

    ISSN: 8756-3282

    DAY: 10

    MONTH: 07

    YEAR: 2007

    Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8504048

    Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Keywords Mesh Terms:

    KEYWORDS: Osteogenesis

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Information

    Substance Name: Caspase 3

    Registry Number: EC 3.4.22.-

    Grant and Affiliation Information for Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells.

    AFFILIATION: Oral and Maxillofacial Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Bone

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News